Book contents
- Synopsis of Neurology, Psychiatry, and Related Systemic Disorders
- Synopsis of Neurology, Psychiatry, and Related Systemic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Section 1 Diagnostics
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- R
- S
- T
- U
- V
- W
- X
- Z
- Section 2 Medication Adverse Effects
- Index
- References
P
from Section 1 - Diagnostics
Published online by Cambridge University Press: 30 May 2019
Book contents
- Synopsis of Neurology, Psychiatry, and Related Systemic Disorders
- Synopsis of Neurology, Psychiatry, and Related Systemic Disorders
- Copyright page
- Dedication
- Contents
- Contributors
- Preface
- Section 1 Diagnostics
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- R
- S
- T
- U
- V
- W
- X
- Z
- Section 2 Medication Adverse Effects
- Index
- References
- Type
- Chapter
- Information
- Synopsis of Neurology, Psychiatry and Related Systemic Disorders , pp. 451 - 554Publisher: Cambridge University PressPrint publication year: 2019
References
Dove, J. Complete fracture of the femur in Paget's disease of the bone. J Bone Joint Surg Br. 1980; 62–B(1): 12–7.Google Scholar
Lyles, KW, Siris, ES, Singer, FR, Meunier, PJ. A clinical approach to diagnosis and management of Paget's disease of bone. J. Bone Miner Res. 2001; 16(8): 1379–87.CrossRefGoogle ScholarPubMed
Deuschl, G, Mischke, G, Schenck, E, Schulte-Monting, J, Lucking, CH. Symptomatic and essential rhythmic palatal myoclonus. Brain. 1990; 113: 1645–72.Google Scholar
Zadikoff, C, Lang, AE, Klein, C. The ‘essentials’ of essential palatal tremor: a reappraisal of the nosology. Brain. 2006; 129: 832–40.CrossRefGoogle ScholarPubMed
Vieregge, P, Klein, C, Gehrking, E, Kurtke, D. The diagnosis of ‘essential’ palatal tremor. Neurology. 1997; 49: 248–9Google Scholar
Deuschl, G, Toro, C, Hallett, M. Symptomatic and essential palatal tremor. 2. Differences of palatal movements. Mov Disord. 1994; 9(6): 676–8.Google Scholar
Kadakia, S, McAbee, G. Volitional control of palatal myoclonus. Mov Disord. 1990; 5: 182–3.Google ScholarPubMed
Lemke, J, Scheele, J, Kapapa, T, et al. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013; 14(2): 4163–73. DOI: 10.3390/ijms14024163.Google Scholar
Makarova-Rusher, OV, Ulahannan, S, Greten, TF, Duffy, A. Pancreatic squamous cell carcinoma: a population-based study of epidemiology, clinicopathologic characteristics and outcomes. Pancreas. 2016; 45(10): 1432–7.Google Scholar
Newton, HB, Malkin, MG. Neurological complications of systemic cancer and antineoplastic therapy. (Neurological Disease and Therapy series: Vol 96). Boca Raton, FL: CRC Press; 2016. p. 330.CrossRefGoogle Scholar
Patchell, RA, Tibbs, PA, Walsh, JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322: 494–500.CrossRefGoogle ScholarPubMed
Majumder, H, Chari, ST. Chronic pancreatitis. Lancet. 2016; 387: 1957–66.CrossRefGoogle ScholarPubMed
Rana-Guajardo, AC, Cámara-Lemarroy, CR, Rendón-Ramírez, EJ, et al. Wernicke encephalopathy presenting in a patient with severe acute pancreatitis. JOP. 2012; 13: 104.Google Scholar
Ruggieri, RM, Lupo, I, Piccoli, F. Pancreatic encephalopathy: a 7-year follow-up case report and review of the literature. Neurol Sci. 2002; 23: 203–5.Google Scholar
Tsai, HH, Hsieh, CH, Liou, CW, et al. Encephalopathy and acute axonal sensorimotor polyneuropathy following acute pancreatitis: a case report and review of the literature. Pancreas. 2005; 30(3): 285–7.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Breslau, N, Schultz, LR, Stewart, WF, Lipton, R, Welch, KMA. Headache types and panic disorder: Directionality and specificity. Neurology. 2001; 56(3): 350–4.CrossRefGoogle ScholarPubMed
Cox, BJ, Swinson, RP, Endler, NS, Norton, GR. The symptom structure of panic attacks. Compr Psychiatry. 1994; 35(5): 349–53.Google Scholar
Ley, R. Agoraphobia, the panic attack and the hyperventilation syndrome. Behav Res Ther. 1985; 23(1): 79–81.CrossRefGoogle ScholarPubMed
Reiman, EM, Raichle, ME, Butler, FK, Herscovitch, P, Robins, E. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature. 1984; 310(5979): 683–5.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Beletsky, V, Mirsattari, SM. Epilepsy, Mental health disorders, or both? Epilepsy Res Treat. 2012; Article ID 163731. http://dx.doi.org/10.1155/2012/163731.Google Scholar
Cassem, NH, Stern, TA, Rosenbaum, JF, Jellinek, MS, Fricchione, GL. Massachusetts General Hospital handbook of general hospital psychiatry. 6th ed. St. Louis, MO: Mosby; 2004.Google Scholar
Kessler, RC, Chiu, WT, Jin, R, et al. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survery Replication. Arch Gen Psychiatry. 2006; 63(4): 415–24.Google Scholar
Lyketsos, CG, Kozauer, N, Rabins, PV. Psychiatric manifestations of neurologic disease: Where are we headed? Dialog Clin Neurosci. 2007; 9(2): 111–24.Google Scholar
Nadarajan, V, Perry, RJ, Johnson, J, Werring, DJ. Transient ischemic attack: mimics and chameleons. Pract Neurol. 2013; 14: 23–31.Google Scholar
Rizzo, M, Eslinger, PJ. Principles and practice of behavioral neurology and neuropsychology. Philadelphia, PA: W.B. Saunders; 2004.Google Scholar
Gordon, N. Pantothenate kinase-associated neurodegeneration (Hallevorden-Spatz syndrome). Eur Paediatr Neurol Soc. 2002; (6): 243–7.Google Scholar
Gregory, A, Hayflick, SJ. Neurodegeneration with brain iron accumulation. Folia Neuropathol. 2005; 43(4): 286–96.Google Scholar
Mikati, MA, Yehya, A, Darwish, H, Karam, P, Comair, Y. Deep brain stimulation as a mode of treatment of early onset pantothenate kinase-associated neurodegeneration. Eur J Pediatr Neurol. 2008; 13(1): 61–4.Google Scholar
Shields, DC, Sharma, N, Gale, JT, Eskandar, EN. Pallidal stimulation for dystonia in pantothenate kinase-associated neurodegeneration. Pediatr Neurol. 2007; 37(6): 442–5.Google Scholar
de Almeida, SM. Central nervous system paracoccidioidomycosis: an overview. Braz J Infect Dis. 2005; 9(2): 126–33.Google Scholar
Martinez, R. Epidemiology of paracoccidioidomycosis. Rev Inst Med Trop Sao Paulo. 2015: 57(Suppl 19): 11–20.Google Scholar
Abermil, N, Guillaud-Bataille, M, Burnichon, N, et al. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. J Clin Endocrinol Metab. 2012; 97: E805–9.Google Scholar
Anderson, J, Gulant, RW. Paraganglioma of the cauda equina: a case report. J Neurol Neurosurg Psychiatry. 1987; 50: 100–3.Google Scholar
Bayley, JP, Kunst, HP, Cascon, A, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 2010; 11: 366–72.Google Scholar
Kirmani, S, Young, WF. Hereditary paraganglioma-pheochromocytoma syndromes. May 21, 2008. Updated Nov 6, 2014. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017.Google Scholar
Papathomas, TG, de Krijger, RR, Tischler, AS. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Semin Diagn Pathol. 2013; 30(3): 207–23. DOI: 10.1053/j.semdp.2013.06.006.CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Paragonimiasis. www.cdc.gov. Accessed Sep 4, 2018.Google Scholar
Johnson, RJ, Jong, EC, Dunning, SB, et al. Paragonimiasis: diagnosis and the use of praziquantel in treatment. Rev Infect Dis 1985; 7: 200.CrossRefGoogle ScholarPubMed
Kim, MK, Cho, BM, Yoon, DY. Imaging features of intradural spinal paragonimiasis: A case report Br J Radiol. 2011 Apr; 84(1000): e72–e74.CrossRefGoogle ScholarPubMed
Xia, Y, Ju, Y, Chen, J, You, C. Cerebral paragonimiasis: a retrospective analysis of 27 cases. J Neurosurg Pediatr 2015; 15: 101.CrossRefGoogle ScholarPubMed
Aminoff, MJ, Josephson, SA, eds. Aminoff's neurology and general medicine. 5th ed. London, UK: Elsevier; 2014.Google Scholar
Ka, A, Britton, P, Troedson, C, et al. Mild encephalopathy with reversible splenial lesion: An important differential of encephalitis. Eur J Paediatr Neurol. 2015; 19(3): 377–82.Google Scholar
Fry, AM, Curns, AT, Harbour, K, et al. Seasonal trends of human parainfluenza viral infections: United States, 1990–2004. Clin Infect Dis. 2006; 43(8): 1016–22. Epub 2006 Sep 13.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.CrossRefGoogle ScholarPubMed
Lancaster, E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2, Neuro-Oncology): 452–75. DOI: 10.1212/01.CON.0000464180.89580.88.Google Scholar
Muppidi, S, Vernino, S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014; 20(5, Peripheral Nervous System Disorders): 1359–72. DOI: 10.1212/01.CON.0000455876.53309.ec.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.Google Scholar
Lancaster, E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2, Neuro-Oncology): 452–75. DOI: 10.1212/01.CON.0000464180.89580.88.Google Scholar
Muppidi, S, Vernino, S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014; 20(5, Peripheral Nervous System Disorders): 1359–72. DOI: 10.1212/01.CON.0000455876.53309.ec.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.Google Scholar
Lancaster, E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2, Neuro-Oncology): 452–75. DOI: 10.1212/01.CON.0000464180.89580.88.Google Scholar
Muppidi, S, Vernino, S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014; 20(5, Peripheral Nervous System Disorders): 1359–72. DOI: 10.1212/01.CON.0000455876.53309.ec.Google Scholar
Rosenfeld, MR, Dalmau, JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn). 2012; 18(2, Neuro-Oncology): 366–83. DOI: 10.1212/01.CON.0000413664.42798.aa.Google ScholarPubMed
Turk, HM, et al. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2009; 18(1): 73–5.Google Scholar
Arroyo, HA, Tringler, N. Opsoclonus-myoclonus syndrome. Medicina (B Aires). 2009; 69(1 Pt 1): 64–70.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Blumkin, L, Lerman-Sagie, T. Opsoclonus myoclonus ataxia syndrome in Israel. Harefuah. 2010; 149(1): 24–8, 63.Google Scholar
Catsman-Berrevoets, CE, Aarsen, FK, van Hemsbergen, ML, et al. Improvement of neurological status and quality of life in children with opsoclonus myoclonus syndrome at long-term follow-up. Pediatr Blood Cancer. 2009; 53(6): 1048–53.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.CrossRefGoogle ScholarPubMed
Matsumoto, H, Ugawa, Y. Paraneoplastic opsoclonus-myoclonus syndrome: a review. Brain Nerve. 2010; 62(4): 365–9.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.Google Scholar
Lancaster, E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2, Neuro-oncology): 452–75. DOI: 10.1212/01.CON.0000464180.89580.88.Google ScholarPubMed
Nicolle, MW. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum (Minneap Minn). 2016; 22(6, Muscle and Neuromuscular Junction Disorders): 1978–2005. DOI: 10.1212/CON.0000000000000415.Google Scholar
Bataller, L, Dalmau, J. Paraneoplastic disorders of the nervous system. Continuum (Minneap Minn). 2005; 11(5, Neuro-Oncology): 69–92. DOI: 10.1212/01.con.0000293680.24426.ae.Google Scholar
Honnorat, J, Antoine, J-C. Paraneoplastic neurological syndromes. Orphanet J Rare Dis. 2007; 2: 22. DOI: 10.1186/1750-1172-2-22.Google Scholar
Lancaster, E. Paraneoplastic disorders. Continuum (Minneap Minn). 2015; 21(2, Neuro-oncology): 452–75. DOI: 10.1212/01.CON.0000464180.89580.88.Google Scholar
Muppidi, S, Vernino, S. Paraneoplastic neuropathies. Continuum (Minneap Minn). 2014; 20(5, Peripheral Nervous System Disorders): 1359–72. DOI: 10.1212/01.CON.0000455876.53309.ec.Google Scholar
Nicolle, MW. Myasthenia gravis and Lambert-Eaton myasthenic syndrome. Continuum (Minneap Minn). 2016; 22(6, Muscle and Neuromuscular Junction Disorders): 1978–2005. DOI: 10.1212/CON.0000000000000415.Google Scholar
Vernino, S. Paraneoplastic disorders affecting the neuromuscular junction or anterior horn cell. Continuum (Minneap Minn). 2009; 15(1, Myasthenic Disorders and ALS): 132–46. DOI: 10.1212/01.CON.0000300011.79845.eb.Google Scholar
Kim, DW, et al. Parietal lobe epilepsy: the semiology, yield of diagnostic workup, and surgical outcome. Epilepsia. 2004; 45(6): 641–9.Google Scholar
Baloh, RW, Furman, JM, Yee, RD. Dorsal midbrain syndrome: Clinical and oculographic findings. Neurology. 1985; 35: 54.Google Scholar
Lee, AG, Brazis, PW. Clinical pathways in neuro-ophthalmology: an evidence-based approach. New York: Thieme; 1998.Google Scholar
Pringsheim, T, Jette, N, Frolkis, A, Steeves, TD. The prevalence of Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2014; 29: 1583.Google Scholar
de Lau, LM, Breteler, MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006; 5: 525.Google Scholar
Braak, H, Del Tredici, K, Rub, U, de Vos, RAI et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 2003; 24: 197–211.CrossRefGoogle ScholarPubMed
Gelb, DJ, Oliver, E, Gilman, S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999; 56: 33.Google Scholar
Gardner, RC, Burke, JF, Nettiksimmons, J, et al. Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol. 2015; 77(6): 987–95.Google Scholar
Klein, C, Schneider, SA, Lang, AE. Hereditary parkinsonism: Parkinson disease look-alikes – an algorithm for clinicians to “PARK” genes and beyond. Mov Disord. 2009; 24: 2042.Google Scholar
Gaeta, M, Frosina, P, Loria, G, Di Pietro, A, De Renzis, C. A case of perineural metastatic diffusion along the facial nerve: its computed tomographic demonstration and the radiotherapy considerations. Radiol Med. 1994; 87(6): 870–2.Google Scholar
Kumar, PP, Patil, AA, Ogren, FP, Johansson, SL, Reeves, MA. Intracranial skip metastasis from parotid and facial skin tumors: mechanism, diagnosis, and treatment. J Nat Med Assoc. 1993; 85(5) 369–74.Google Scholar
Newton, HB, Malkin, MG. Neurological complications of systemic cancer and antineoplastic therapy. (Neurological Disease and Therapy series: Vol 96). Boca Raton, FL: CRC Press; 2016. p. 80.Google Scholar
Renehan, AG, Gleave, EN, Slevin, NJ, McGurk, M. Clinico-pathological and treatment-related factors influencing survival in parotid cancer. Br J Cancer. 1999; 80(8): 1296–300.Google Scholar
Tullio, A, Marchetti, C, Sesenna, E, et al. Treatment of carcinoma of the parotid gland: The results of a multicenter study. J Oral Maxillofac Surg. 2001; 59(3): 263–70.Google Scholar
Antonaci, F, Sjaastad, O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache. 1989; 29: 648–56.Google Scholar
Boes, CJ, Matharu, MS, Goadsby, PJ. The paroxysmal hemicraniatic syndrome. Cephalalgia. 2003; 23: 24–8.Google Scholar
Cittadini, E, Matharu, MS, Goadsby, PJ. Paroxysmal hemicrania: a prospective clinical study of 31cases. Brain. 2008; 131(Pt4): 1142–55.Google Scholar
Prakash, S, Patell, R. Paroxysmal hemicrania: an update. Curr Pain Headache Rep. 2014; 18: 407.Google Scholar
Bruno, MK, Hallett, M, Gwinn-Hardy, K, et al. Critical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004; 63(12): 2280–7.Google Scholar
Bhatia, KP. Familial (idiopathic) paroxysmal dyskinesias: an update. Semin Neurol. 2001; 21(1): 69–74.Google Scholar
Van Rootselaar, AF, van Westrum, SS, Velis, DN, Tijssen, MA. The paroxysmal dyskinesias. Pract Neurol. 2009; 9(2): 102–9.Google Scholar
Gardiner, AR, Jaffer, F, Dale, RC, et al. The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain. 2015; 138(12): 3567–80.CrossRefGoogle ScholarPubMed
Wang, JL, Cao, L, Li, XH, et al. Identification of Prrt2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain. 2011; 134(12): 3493–501.Google Scholar
Hur, YJ, Hwang, T. Secondary paroxysmal dyskinesia associated with 2009 H1N1 infection. Korean J Pediatr. 2013; 56(1): 42–4.Google Scholar
Meppiel, E, Crassard, I, Peffault de Latour, R, et al. Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature. Medicine (Baltimore). 2015; 94: e362.Google Scholar
Schrezenmeier, H, Muus, P, Socié, G, et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014; 99: 922–9.Google Scholar
Mayo Clinic Staff. Patent ductus arteriosus (PDA). Dec 16, 2014. Available from www.mayoclinic.org/diseases-conditions/patent-ductus-arteriosus/basics/complications/con-20028530 Accessed Jul 6, 2015.Google Scholar
Webb, GD, Smallhorn, J, Therrien, J, Redington, AN. Congenital heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart disease: A textbook of cardiovascular medicine. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2015. pp. 1413–14.Google Scholar
Mayo Clinic Staff. Patent foramen ovale. Jul 16, 2015. Available from www.mayoclinic.org/diseases-conditions/patent-foramen-ovale/basics/causes/con-20028729. Accessed Jul 19, 2015.Google Scholar
Webb, GD, Smallhorn, J, Therrien, J, Redington, AN. Congenital heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart disease: A textbook of cardiovascular medicine. 10th ed. Philadelphia, PA: Elsevier/Saunders; 2015. pp. 1409–10.Google Scholar
Benke, T. Peduncular hallucinosis: A syndrome of impaired reality monitoring. J Neurol. 2006; 253: 1561–71.Google Scholar
Penney, L, Galameau, D. Peduncular hallucinosis: A case report. Oschner J. 2014(Fall); 14(3): 456–8.Google Scholar
Friedland, DR, Wackym, PA. Clinical forum: a critical appraisal of spontaneous perilymphatic fistulas of the inner ear. Am J Otol. 1999; 20: 261–76.Google Scholar
Minor, LB. Labyrinthine fistulae: pathobiology and management. Curr Opin Otolaryngol Head Neck Surg. 2003; 11: 340–6.Google Scholar
Smouha, EE, Bojrab, DI. Lateral semicircular canal fistula. In Cholesteatoma. New York, NY: Thieme; 2011. p. 88.Google Scholar
Sorenson, EJ, Sima, AA, Blaivas, M, Sawchuk, K, Wald, JJ. Clinical features of perineuritis. Muscle Nerve. 1997; 20(9): 1153–7.Google Scholar
Gaultney, JF. The prevalence of sleep disorders in college students: impact on academic performance. J Am Coll Health. 2010; 59(2): 91–7.Google Scholar
Petrov, ME, Lichstein, KL, Baldwin, CM. Prevalence of sleep disorders by sex and ethnicity among older adolescents and emerging adults: Relations to daytime functioning, working memory and mental health. J Adolesc. 37; 2014: 587–97.Google Scholar
Moore, H, Winkelmann, J, Lin, L, et al. Periodic leg movements during sleep are associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1, MAP2K5/SKOR1, and PTPRD. Sleep. 2014; 37(9): 1535–42.CrossRefGoogle ScholarPubMed
Aurora, RN, Kristo, DA, Bista, SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults – an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses. Sleep. 2012; 35(8): 1039–62.Google Scholar
Merikangas, KR, Zhang, J, Emsellem, H, et al. The structured Diagnostic Interview for Sleep Patterns and Disorders: rationale and initial evaluation. Sleep Med. 2014; 15: 530–5.Google Scholar
Ke, Q, Luo, B, Qi, M, et al. Gender differences in penetrance and phenotype in hypokalemic periodic paralysis. Muscle Nerve. 2013; 47: 41.Google Scholar
Miller, TM, Dias da Silva, MR, Miller, HA, et al. Correlating phenotype and genotype in the periodic paralyses. Neurology. 2004; 63: 1647.Google Scholar
Kasper, DL, Fauci, AS, Hauser, SL, et al., eds. Harrison's principles of internal medicine. 19th ed. New York: McGraw-Hill Education/Medical; 2015.Google Scholar
Ober, KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore). 1992; 71: 109.Google Scholar
Links, TP, Zwarts, MJ, Wilmink, JT, et al. Permanent muscle weakness in familial hypokalaemic periodic paralysis: Clinical, radiological and pathological aspects. Brain. 1990; 113(6): 1873.Google Scholar
Venance, SL, Cannon, SC, Fialho, D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006; 129: 8.Google Scholar
Chen, YC, Fang, JT, Chang, CT, Chou, HH. Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail. 2001; 23: 139.Google Scholar
Pompeo, A, Nepa, A, Maddestra, M, et al. Thyrotoxic hypokalemic periodic paralysis: An overlooked pathology in western countries. Eur J Intern Med. 2007; 18: 380.Google Scholar
Hannon, MJ, Behan, LA, Agha, A. Thyrotoxic periodic paralysis due to excessive L-thyroxine replacement in a Caucasian man. Ann Clin Biochem. 2009; 46: 423.Google Scholar
Chou, HK, Tsao, YT, Lin, SH. An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. Am J Med Sci. 2009; 337: 71.Google Scholar
Manoukian, MA, Foote, JA, Crapo, LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999; 159: 601.Google Scholar
Pothiwala, P, Levine, SN. Analytic review: thyrotoxic periodic paralysis: a review. J Intens Care Med. 2010; 25: 71.Google Scholar
Hsieh, MJ, Lyu, RK, Chang, WN, et al. Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks. Eur J Neurol. 2008; 15: 559.Google Scholar
Shiang, JC, Cheng, CJ, Tsai, MK, et al. Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years. Eur J Endocrinol. 2009; 161: 911.Google Scholar
Griggs, RC, Bender, AN, Tawil, R. A puzzling case of periodic paralysis. Muscle Nerve. 1996; 19: 362.Google Scholar
Lu, KC, Hsu, YJ, Chiu, JS, et al. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med. 2004; 22: 544.Google Scholar
Birkhahn, RH, Gaeta, TJ, Melniker, L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med. 2000; 18: 199.Google Scholar
Conway, MJ, Seibel, JA, Eaton, P. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med. 1974; 81: 332.Google Scholar
Jurkat-Rott, K, Lehmann-Horn, F. Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis. Neurotherapeutics. 2007; 4: 216.Google Scholar
Venance, SL, Cannon, SC, Fialho, D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006; 129: 8.Google Scholar
Gould, RJ, Steeg, CN, Eastwood, AB, et al. Potentially fatal cardiac dysrhythmia and hyperkalemic periodic paralysis. Neurology. 1985; 35: 1208.Google Scholar
Bradley, WG, Taylor, R, Rice, DR, et al. Progressive myopathy in hyperkalemic periodic paralysis. Arch Neurol. 1990; 47: 1013.Google Scholar
McManis, PG, Lambert, EH, Daube, JR. The exercise test in periodic paralysis. Muscle Nerve. 1986; 9: 704.Google Scholar
Kuntzer, T, Flocard, F, Vial, C, et al. Exercise test in muscle channelopathies and other muscle disorders. Muscle Nerve. 2000; 23: 1089.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Hanna, MG, Stewart, J, Schapira, AH, et al. Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). J Neurol Neurosurg Psychiatry. 1998; 65: 248.Google Scholar
Bendheim, PE, Reale, EO, Berg, BO. beta-Adrenergic treatment of hyperkalemic periodic paralysis. Neurology. 1985; 35: 746.Google Scholar
Riggs, JE, Griggs, RC, Moxley, RT 3rd, Lewis, ED. Acute effects of acetazolamide in hyperkalemic periodic paralysis. Neurology. 1981; 31: 725.Google Scholar
Cannon, SC, George, AL. Pathophysiology of myotonia and periodic paralysis. In Asbury, AK, McKhann, GM, McDonald, WI, et al., eds. Diseases of the nervous system. 3rd ed. Cambridge, UK: Cambridge University Press; 2002. p. 1183.Google Scholar
Klingler, W, Lehmann-Horn, F, Jurkat-Rott, K. Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord. 2005; 15: 195.Google Scholar
Brazis, PW, et al., eds. Peripheral nerves. In Localization in clinical neurology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. Chapter 2.Google Scholar
Stewart, JD. Foot drop: where, why and what to do? Pract Neurol. 2008; 8(3): 158–69. DOI: 10.1136/jnnp.2008.149393.CrossRefGoogle ScholarPubMed
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Thase, ME, Fava, M, Halbreich, U, et al. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry. 1996; 53(9): 777–84.Google Scholar
van Elst, LT, Woermann, FG, Lemieux, L, Trimble, MR. Amygdala enlargement in dysthymia – a volumetric study of patients with temporal lobe epilepsy. Biol Psychiatry. 1999; 46(12): 1614–23.Google Scholar
Weissman, MM, Leaf, PJ, Bruce, ML, Florio, L. The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment. Am J Psychiatry. 1988; 145(7): 815–19.Google Scholar
Williams, JW Jr, Barrett, J, Oxman, T, et al. Treatment of dysthymia and minor depression in primary care: a randomized controlled trial in older adults. JAMA. 2000; 284(12): 1519–26.Google Scholar
Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state. N Engl J Med. 1994; 330: 1499–579.Google Scholar
Kinney, HC, Korein, J, Panigrahy, A, Dikkes, P, Goode, R. Neuropathological findings in the brain of Karen Ann Quinlan: the role of the thalamus in the persistent vegetative state. N Engl J Med. 1994; 330: 1469–75.Google Scholar
Posner, JB, Saper, CB. Plum and Posner's diagnosis of stupor and coma. 4th ed. Oxford: Oxford University Press; 2007.Google Scholar
Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters: Assessment and management of patients in the persistent vegetative state (Summary statement). Neurology. 1995; 45: 1015–18.Google Scholar
No authors listed. Position of the American Academy of Neurology on certain aspects of the care and management of the persistent vegetative state patient. Neurology. 1989; 39: 125–6Google Scholar
Larriviere, D, Bonnie, RJ. Terminating artificial nutrition and hydration in persistent vegetative state patients: Current and proposed state laws. Neurology. 2006; 66: 1624–8.CrossRefGoogle ScholarPubMed
Giacino, JT, et al. The minimally conscious state: definition and diagnostic criteria. Neurology. 2002; 58(3): 349–53.Google Scholar
Cherry, JD, Heininger, U. Pertussis and other Bordetella infections. In Feigin, RD, Cherry, JD, Demmler-Harrison, GJ, et al., eds. Textbook of pediatric infectious diseases. Vol. 1. Philadelphia, PA: Saunders/Elsevier; 2009. pp. 1683–706.Google Scholar
Sanghi, V. Neurologic manifestations of diphtheria and pertussis. In Biller, J, Ferro, JM, eds. Neurologic aspects of systemic disease Part III. Handbook of Clinical Neurology. Vol 121. 3rd Series. Philadelphia, PA: Elsevier; 2014.Google Scholar
Brenner, S. PCP toxicity. Updated Feb 1, 2018. https://emedicine.medscape.com/article/1010821-overview. Accessed Sep 17, 2018.Google Scholar
Hallucinogens.com. PCP effects on the brain. http://hallucinogens.com/pcp/pcp-effects-on-the-brain/. Accessed Sep 6, 2018.Google Scholar
National Institute of Drug Abuse. What are the effects of common dissociative drugs on the brain and body? Feb 2015. https://www.drugabuse.gov/publications/research-reports/hallucinogens-dissociative-drugs/what-are-effects-common-dissociative-drugs-brain-body. Accessed Sep 6, 2018.Google Scholar
Leuzzi, V, et al. Biochemical, clinical and neuroradiological (MRI) correlations in late-detected PKU patients. J Inherit Metab Dis. 1995; 18(5): 624–34.Google Scholar
Leuzzi, V, et al. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 Tesla MRI and magnetic resonance spectroscopy (1H MRS) study. J Inherit Metab Dis. 2007; 30(2): 209–16.Google Scholar
Rahja, R, et al. Mental health and social functioning in early treated phenylketonuria: the PKU-COBESO study. Mol Genet Metab. (2013); 110(Suppl): S57–S61.Google Scholar
Smith, I, Knowles, J. Behavior in early treated PKU: a systematic review. Eur J Pediatr. 2000; 159(2): S89–93.Google Scholar
Abermil, N, Guillaud-Bataille, M, Burnichon, N, et al. TMEM127 screening in a large cohort of patients with pheochromocytoma and/or paraganglioma. J Clin Endocrinol Metab. 2012; 97: E805–9.Google Scholar
Anderson, J, Gulant, RW. Paraganglioma of the cauda equina: a case report. J Neurol Neurosurg Psychiatry. 1987; 50: 100–3.Google Scholar
Bayley, JP, Kunst, HP, Cascon, A, et al. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma. Lancet Oncol. 2010; 11: 366–72.Google Scholar
Fishbein, L. Pheochromocytoma and paraganglioma: genetics, diagnosis, and treatment. Hematol Oncol Clin North Am. 2016; 30(1): 135–50. DOI: 10.1016/j.hoc.2015.09.006. Epub 2015 Oct 23.Google Scholar
Hrabovsky, EE, McLellan, D, Horton, JA, Klingberg, WG. Catheter embolization: preparation of patient with pheochromocytoma. J Pediatr Surg. 1982; 17(6): 849–50.Google Scholar
Kirmani, S, Young, WF. Hereditary paraganglioma-pheochromocytoma syndromes. May 21, 2008. Updated Nov 6, 2014. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2017.Google Scholar
Naguib, M, Caceres, M, Thomas, CR Jr, Herman, TS, Eng, TY. Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol. 2002; 25(1): 42–4.Google Scholar
Papathomas, TG, de Krijger, RR, Tischler, AS. Paragangliomas: update on differential diagnostic considerations, composite tumors, and recent genetic developments. Semin Diagn Pathol. 2013; 30(3): 207–23. DOI: 10.1053/j.semdp.2013.06.006.Google Scholar
You, D, Ren, R, Chen, E, et al. Radiotherapy for urinary bladder pheochromocytoma with invasion of the prostate: A case report and literature review. Mol Clin Oncol. 2016; 4(6): 1060–2. Epub 2016 Mar 17.Google Scholar
Beck, G, Shinzawa, K, Hayakawa, H, et al. Deficiency of calcium-independent phospholipase A2 beta induces brain iron accumulation through upregulation of divalent metal transporter 1. PLoS One. 2015; 10(10): e0141629. DOI: 10.1371/journal.pone.0141629.Google Scholar
Bernardi, B. MRI findings in patients with clinical onset consistent with infantile neuroaxonal dystrophy (INAD), literature review, clinical and MRI follow-up. Neuroradiol J. 2011; 24(2): 202–14. Epub 2011 May 11.Google Scholar
Illingworth, MA, Meyer, E, Chong, WK, et al. PLA2G6-associated neurodegeneration (PLAN): Further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease. Mol Genet Metab. 2014; 112(2): 183–9. DOI: 10.1016/j.ymgme.2014.03.008.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Bhatia, MS, Gupta, R. Pica responding to SSRI: An OCD spectrum disorder? World J Biol Psychiatry. 2009; 10(4–3): 936–8.Google Scholar
Ruddock, JC. Lead poisoning in children: with special reference to pica. J Am Med Assoc. 1924; 82(21): 1682–4.Google Scholar
Singhi, S, Singhi, P, Adwani, GB. Role of psychosocial stress in the cause of pica. Clin Pediatr. 1981; 20(12): 783–5.Google Scholar
Amato-Watkins, AC, Lammie, A, Hayhurst, C, Leach, P. Pineal parenchymal tumours of intermediate differentiation: An evidence-based review of a new pathological entity. Br J Neurosurg. 2016; 30(1): 11–5. DOI: 10.3109/02688697.2015.1096912.Google Scholar
Ito, T, Kanno, H, Sato, K, et al. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation. World Neurosurg. 2014; 81(5–6): 783–9. DOI: 10.1016/j.wneu.2013.02.007.Google Scholar
Kwak, J, Shim, JK, Kim, DS, et al. Isolation and characterization of tumorspheres from a recurrent pineoblastoma patient: Feasibility of a patient-derived xenograft. Int J Oncol. 2016; 49(2): 569–78. DOI: 10.3892/ijo.2016.3554.Google Scholar
Raleigh, DR, Solomon, DA, Lloyd, SA, et al. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol. 2017; 19(1): 78–88. DOI: 10.1093/neuonc/now105.Google Scholar
Schild, SE, Scheithauer, BW, Schomberg, PJ, et al. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993; 72(3): 870–80.Google Scholar
Al-Hussaini, M, Sultan, I, Gajjar, AJ, Abuirmileh, N, Qaddoumi, I. Pineal gland tumors: experience from the Seer database. J Neurooncol. 2009; 94(3): 351–8. DOI: 10.1007/s11060-009-9881-9.Google Scholar
Ito, T, Kanno, H, Sato, K, et al. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation. World Neurosurg. 2014; 81(5–6): 783–9. DOI: 10.1016/j.wneu.2013.02.007.Google Scholar
Kwak, J, Shim, JK, Kim, DS, et al. Isolation and characterization of tumorspheres from a recurrent pineoblastoma patient: Feasibility of a patient-derived xenograft. Int J Oncol. 2016; 49(2): 569–78. DOI: 10.3892/ijo.2016.3554.Google Scholar
Mottolese, C, Szathmari, A, Beuriat, PA. Incidence of pineal tumours. A review of the literature. Neurochirurgie. 2015; 61(2–3): 65–9. DOI: 10.1016/j.neuchi.2014.01.005.Google Scholar
Raleigh, DR, Solomon, DA, Lloyd, SA, et al. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome. Neuro Oncol. 2017; 19(1): 78–88. DOI: 10.1093/neuonc/now105.Google Scholar
Schild, SE, Scheithauer, BW, Schomberg, PJ, et al. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects. Cancer. 1993; 72(3): 870–80.Google Scholar
Cass, S. Piriformis syndrome: a cause of nondiscogenic sciatica. Curr Sports Med Rep. 2015; 14(1): 41–4. DOI: 10.1249/JSR.0000000000000110. Review.Google Scholar
Smoll, NR. Variations of the piriformis and sciatic nerve with clinical consequence: a review. Clin Anat. 2010; 23(1): 8–17.Google Scholar
Nawar, RN, AbdelMannan, D, Selman, WR, Arafah, BM. Pituitary tumor apoplexy: a review. J Intens Care Med. 2008; 23(2): 75–90.Google Scholar
Vaphiades, MS. Pituitary apoplexy. Medscape. Updated Sep 20, 2017. Available from https://emedicine.medscape.com/article/1198279-overview. Available from https://emedicine.medscape.com/article/1198279-overview. Accessed Sep 25, 2018.Google Scholar
Arafah, BM, Nasrallah, MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001; 8(4): 287–305.Google Scholar
Chaudhary, V, Bano, S. Imaging of the pituitary: Recent advances. Ind J Endocrinol Metab. 2011; 15(Suppl 3): S216–23. DOI: 10.4103/2230-8210.84871.Google Scholar
Ironside, JW. Best practice No 172: Pituitary gland pathology. J Clin Pathol. 2003; 56: 561–8.Google Scholar
Huguet, I, Clayton, R. Pituitary-hypothalamic tumor syndromes: Adults. Endotext [Internet]. South Dartmouth, MA: MDText.com, Inc.; 2000. Available from https://www.ncbi.nlm.nih.gov/books/NBK278946/. Accessed Jul 3, 2015.Google Scholar
Robertson, GL. Diabetes insipidus: differential diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2016; 30(2): 205–18.Google Scholar
Utz, AL, Klibanski, A. Pituitary disorders. Continuum (Minneap Minn). 2009; 15(2, Neurology): 17–36.Google Scholar
Malkani, RG, Tallman, M, Gottardi-Littell, N, et al. Bing-Neel syndrome: an illustrative case and a comprehensive review of the published literature. J Neurooncol. 2010; 96: 301–12.Google Scholar
Sobol, U, Stiff, P. Neurologic aspects of plasma cell disorders. Handb Clin Neurol. 2014; 120: 1083–99.Google Scholar
Nobile-Orazio, E. Neuropathy and monoclonal gammopathy. Handb Clin Neurol. 2013; 115: 443–59.Google Scholar
Dispenzieri, A, Kyle, RA, Lacy, MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003; 101: 2496.Google Scholar
Dupont, SA, Dispenzieri, A, Mauermann, ML, et al. Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics. Neurology. 2009; 73: 1308.Google Scholar
Aminoff, MJ, Josephson, SA, eds. Aminoff's neurology and general medicine. 5th ed. London, UK: Elsevier; 2014.Google Scholar
Aylward, RB, Linkins, J. Polio eradication: mobilizing and managing the human resources. Bull World Health Org. 2005; 83(4): 268–73.Google Scholar
Grist, NR, Bell, EJ. Paralytic poliomyelitis and nonpolio enteroviruses: studies in Scotland. Rev Infect Dis. 1984; 6(Suppl 2): S385–6.Google Scholar
Robbins, FC, Nightingale, EO. Selective primary health care: Strategies for control of disease in the developing world. IX. Poliomyelitis. Rev Infect Dis. 1983; 5(5): 957–68.Google Scholar
Ramachandran, TS, Roos, RP. Periarteritis nodosa. Medlink Neurology. Updated Nov 14, 2017. San Diego: Medlink Corporation. Available from https://emedicine.medscape.com/article/330717-overview. Accessed Nov 25, 2018.Google Scholar
Cao, M, Olsen, RJ, Zu, Y. Polycythemia vera: new clinicopathologic perspectives. Arch Pathol Lab Med. 2006; 130: 1126–32.Google Scholar
Buttgereit, F, Dejaco, C, Matteson, EL, Dasgupta, B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016; 315(22): 2442–58.Google Scholar
Caylor, TL, Perkins, A. Recognition and management of polymyalgia rheumatica and giant cell arteritis. Am Fam Physician. 2013; 88(10): 676–84.Google Scholar
Amato, AA, Greenberg, SA. Inflammatory myopathies. Continuum (Minneap Minn). 2013; 19(6): 1615–33.Google Scholar
Brazis, PW, et al., eds. Peripheral nerves. In Localization in clinical neurology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. Chapter 2.Google Scholar
Hanewinckel, R, van Oijen, M, Ikram, MA, van Doorn, PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016; 31: 5–20. DOI: 10.1007/s10654-015-0094-6.Google Scholar
Visser, N. Chronic idiopathic axonal polyneuropathy is associated with the metabolic syndrome. Diabetes Care. 2013; 36(4): 817–22.Google Scholar
Arboix, A, Arbe, C, Garcia-Eroles, L, et al. Infarctions in the vascular territory of the posterior cerebral artery: clinical features in 232 patients. BMC Res Notes. 2011; 4: 329–35.Google Scholar
Cereda, C, Carrera, E. Posterior cerebral artery territory infarctions. Front Neurol Neurosci. 2012; 30: 128–31.Google Scholar
Arboix, A, Arbe, C, Garcia-Eroles, L, et al. Infarctions in the vascular territory of the posterior cerebral artery: clinical features in 232 patients. BMC Res Notes. 2011; 4: 329–35.Google Scholar
Cereda, C, Carrera, E. Posterior cerebral artery territory infarctions. Front Neurol Neurosci. 2012; 30: 128–31.Google Scholar
Rodriguez Frontal, M, Kerrison, JB, Garcia, R, Oria, V. Ischemic optic neuropathy. Semin Neurol. 2007; 27(3): 221–32Google Scholar
Fischer, M, Schmutzhard, E. Posterior reversible encephalopathy syndrome. J Neurol. 2017; 264(8): 1608–16.Google Scholar
Hinchey, J, Chaves, C, Appignani, B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996; 334: 494.Google Scholar
Christo, PJ, et al. Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management. Drugs Aging. 2007; 24(1): 1–19.Google Scholar
Denny-Brown, D, et al. Pathologic features of herpes zoster: A note on ‘geniculate herpes’. Arch Neurol Psychiatr. 1944; 51: 216.Google Scholar
Johnson, R. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010; 9(Suppl 3): 21–6.Google Scholar
Alper, G. Acute disseminated encephalomyelitis. J Child Neurol. 2012; 27(11): 1408–25.Google Scholar
Huynh, W, Cordato, DJ, Kehdi, E, Masters, LT, Dedousis, C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008; 15(12): 1315–22.Google Scholar
Alper, G. Acute disseminated encephalomyelitis. J Child Neurol. 2012; 27(11): 1408–25.Google Scholar
Wingerchuk, DM. Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep. 2003; 3(3): 256–64.Google Scholar
Ahmed, SV, Jayawarna, C, Jude, E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006; 82: 713–16Google Scholar
Kuntz, KM, Kokmen, E, Stevens, JC, et al. Post-lumbar puncture headaches: experience in 501 consecutive procedures. Neurology. 1992; 42: 1884–7.Google Scholar
Niall, CT, Globerson, JA, de Rosayro, MA. Epidural blood patch for postdural puncture headache: it's never too late. Anesth Anal. 1986; 65: 895–6.Google Scholar
Olsen, J, Bousser, M-G, Diener, H-C, et al. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004; 24: 9–160.Google Scholar
Thomas, S-R, Jamieson, D-R, Muir, K-W. Randomised controlled trial of atraumatic versus standard needles for diagnostic lumbar puncture. BMJ (Clin Res Ed). 2000; 3210: 986–90.Google Scholar
Turnbull, DK, Shepherd, DB. Post-dural puncture headache: pathogenesis, prevention and treatment. Br J Anaesth. 2003; 91: 718–29.Google Scholar
Padovan, CS, Sostak, P, Straube, A. [Neurological complications after organ transplantation]. Der Nervenarzt. 2000; 71(4): 249–58.Google Scholar
Živković, SA. Neurologic complications after liver transplantation. World J Hepatol. 2013; 5(8): 409–16. DOI: 10.4254/wjh.v5.i8.409.Google Scholar
Bashir, . Neurologic complications of organ transplantation. Curr Treat Options Neurol. 2001; 3(6): 543–54.Google Scholar
Mathew, RM, Rosenfeld, MR. Neurologic complications of bone marrow and stem-cell transplantation in patients with cancer. Curr Treat Options Neurol. 2007; 9(4): 308–31.Google Scholar
Patchell, RA. Neurological complications of organ transplantation and immunosuppressive agents. In Aminoff, M, ed. Neurology and general medicine. 4th ed. London: Churchill Livingstone; 2007. pp. 873–85.Google Scholar
Pruitt, AA, Grus, F, Rosenfeld, MR. Neurological complications of solid organ transplantation. The Neurohospitalist. 2012; 3(3): 152–66.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Rauch, SL, van der Kolk, BA, Fisler, RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry. 1996; 53(5): 380–7.Google Scholar
Shin, LM, Wright, CI, Cannistraro, PA, et al. A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder. Arch Gen Psychiatry. 2005; 62(3): 273–81.Google Scholar
Taylor, HR. Prazosin for treatment of nightmares related to post traumatic stress disorder. Am J Health Syst Pharm. 2008; 65(8): 716–22.Google Scholar
Yule, W. Posttraumatic stress disorder. In Ollendick, , King, NJ, Yule, W, eds. International handbook of phobic and anxiety disorders in children and adolescents. New York: Springer US; 1994. pp. 223–40.Google Scholar
Zarei, MR, Shabani, M, Chamani, G, et al. Migraine patients have higher prevalence of PTSD symptoms in comparison to chronic tension type headache and healthy subjects: a case control study. Acta Odontol Scand. 2016; 74(8): 633–5.Google Scholar
Jacob, G, Costa, F, Shannon, JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med. 2000; 343: 1008–14.Google Scholar
Raj, SR. Postural orthostatic tachycardia syndrome (POTS). Circulation. 2013; 127(23): 2336–42.Google Scholar
Thieben, MJ, Sandroni, P, Sletten, DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007; 82: 308–13.Google Scholar
Tena Rosser, AP. Pediatric neurology: a case based review. Lippincott Williams & Wilkins; 2007.Google Scholar
Ropper, AH, Samuels, MA, Klein, JP. The myotonias, periodic paralyses, cramps, spasms, and states of persistent muscle fiber activity. In Adams & Victor's principles of neurology. 10th ed. New York, NY: McGraw-Hill; 2014. Chapter 50.Google Scholar
Patcek, LJ, Tawil, R, Griggs, RC, Storvick, D, Leppert, M. Linkage of atypical myotonia congenita to a sodium channel locus. Neurology. 1992; 42(2): 431.Google Scholar
Science Direct. Potassium-aggravated myotonia. Available from https://www.sciencedirect.com/topics/neuroscience/potassium-aggravated-myotonia. Accessed Sep 25, 2018.Google Scholar
Trudell, RG, Kaiser, KK, Griggs, R. Actetazolamide-responsive myotonia congenita. Neurology. 1987; 37(3): 488.Google Scholar
Driscoll, DJ, Miller, JL, Schwartz, S, et al. Prader–Willi syndrome. Oct 6, 1998. Updated Feb 4, 2016. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2016. Available from: www.ncbi.nlm.nih.gov/books/NBK1330/. Accessed Sep 11, 2018.Google Scholar
Miller, J, Kranzler, J, Liu, Y, et al. Neurocognitive findings in Prader-Willi syndrome and early-onset morbid obesity. J Pediatr. 2006; 149: 192–8.Google Scholar
Descheemaeker, MJ, Govers, V, Vermeulen, P, Fryns, JP. Pervasive developmental disorders in Prader-Willi syndrome: the Leuven experience in 59 subjects and controls. Am J Med Genet A. 2006; 140: 1136–42.Google Scholar
Wigren, M, Hansen, S. ADHD symptoms and insistence on sameness in Prader-Willi syndrome. J Intellect Disabil Res. 2005; 49: 449–56.Google Scholar
Iughetti, L, Bosio, L, Corrias, A, et al. Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. Eur J Pediatr. 2008; 167: 701–2.Google Scholar
Bartsch, E, Medcalf, KE, Park, AL, Ray, JG. High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016; 353: i1753. DOI: 10.1136/bmj.i1753.Google Scholar
Duhig, KE, Shennan, AH. Recent advances in the diagnosis and management of pre-eclampsia. F1000Prime Rep. 2015; 7: 24. DOI: 10.12703/P7-24.Google Scholar
Powe, CE, Levine, RJ, Karumanchi, SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011; 123(24): 2856–69. DOI: 10.1161/CIRCULATIONAHA.109.853127.Google Scholar
WHO. Recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Hatzimouratidis, K, Amar, E, Eardley, I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010; 57(5): 804–14.Google Scholar
Waldinger, MD. The neurobiological approach to premature ejaculation. J Urol. 2002; 168(6): 2359–67.Google Scholar
Waldinger, MD, Hengeveld, MW, Zwinderman, AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994; 151(9): 1377–9.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Epperson, CN, Haga, K, Mason, GF, et al. Cortical γ-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry. 2002; 59(9): 851–8.Google Scholar
Grady-Weliky, T. Premenstrual dysphoric disorder. New Engl J Med. 2003; 348(5): 433–8.Google Scholar
Yonkers, KA, Halbreich, U, Freeman, E, et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: a randomized controlled trial. JAMA. 1997; 278(12): 983–8.Google Scholar
Yonkers, KA, Brown, C, Pearlstein, TB, et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005; 106(3): 492–501.Google Scholar
El-Hattab, AW. Systemic primary carnitine deficiency. Mar 15, 2012. Updated Jun 26, 2014. In Pagon, RA, Adam, MP, Ardinger, HH, et al., eds. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2015. Available from: www.ncbi.nlm.nih.gov/books/NBK84551/. Accessed Sep 12, 2018.Google Scholar
Magoulas, PL, El-Hattab, AW. Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2012; 7: 68. DOI: 10.1186/1750-1172-7-68.Google Scholar
Online Mendelian Inheritance in Man (OMIM). Carnitine deficiency, systemic primary; CDSP. McKusick, VA, ed. Johns Hopkins University. Updated Jul 7, 2014. Entry Number 212140. Available at http://omim.org/entry/212140. Accessed Sep 12, 2018.Google Scholar
Dempsey, JA, Smith, CA, Przybylowski, T, et al. The ventilator responsiveness to CO2 below eupnoea as a determinant of ventilator stability in sleep. J Physiol. 2004; 560: 1–11.Google Scholar
Eckert, DJ, Jordan, AS, Merchia, P, et al. Central sleep apnea: Pathophysiology and treatment. Chest. 2007; 131: 595–607.Google Scholar
Sateia, M, Berry, RB, Bornemann, MC, et al. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.Google Scholar
Quinzii, CM, Dimauro, S, Hirano, M. Human coenzyme Q10 deficiency. Neurochem Res. 2007; 32: 723–7.Google Scholar
Rodriguez-Pla, A, Monoch, DA. Primary angiitis of the central nervous system in adults and children. Rheum Dis Clin North Am. 2015; 41(1): 47–62.Google Scholar
Al Bahrani, B, Henderson, C, Delaney, G. Primary central nervous system lymphoma and subcutaneous metastases. J Neurooncol. 2000; 47(2): 141–4.Google Scholar
Carnevale, J, Rubenstein, JL. The challenge of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2016; 30(6): 1293–316.Google Scholar
Fitzsimmons, A, Upchurch, K, Batchelor, T. Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am. 2005; 19(4): 689–703, vii.Google Scholar
Herrlinger, U, Schabet, M, Bitzer, M, Petersen, D, Krauseneck, P. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol. 1999; 43(3): 219–26.Google Scholar
Ko, JH, Lu, PH, Tang, TC, Hsu, YH. Metastasis of primary CNS lymphoma along a ventriculoperitoneal shunt. J Clin Oncol. 2011; 29(34): e823–4Google Scholar
Korfel, A, Schlegel, U. Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013; 9(6): 317–27.Google Scholar
Masroujeh, R, Otrock, ZK, Yamout, B, Jabbour, MN, Bazarbachi, A. Myasthenia gravis developing in a patient with CNS lymphoma. Int J Hematol. 2010; 91(3): 522–4Google Scholar
Matsuyama, J, Ichikawa, M, Oikawa, T, et al. Primary CNS lymphoma arising in the region of the optic nerve presenting as loss of vision: 2 case reports, including a patient with a massive intracerebral hemorrhage. Brain Tumor Pathol. 2014; 31(3): 222–8Google Scholar
Nayak, L, Pentsova, E, Batchelor, TT. Primary CNS lymphoma and neurologic complications of hematologic malignancies. Continuum (Minneap Minn). 2015; 21(2): 355–72.Google Scholar
Rees, J, Wen, P, eds. Blue books of neurology: Neuro-oncology. Vol 36. Elsevier Inc. 2010; pp. 201–17.Google Scholar
Cutrer, FM, Boes, CJ. Cough, exertional, and sex headaches. Neurol Clin North Am. 2004; 22: 133–49.Google Scholar
Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia. 2004; 24(Suppl 1): 1–160.Google Scholar
Cutrer, FM, Boes, CJ. Cough, exertional, and sex headaches. Neurol Clin North Am. 2004; 22: 133–49.Google Scholar
Grace, A, Horgan, J, Breathnach, K, et al. Anginal headache and its basis. Cephalalgia. 1997; 17: 195–6.Google Scholar
Rasmussen, BK, Olesen, J. Symptomatic and nonsymptomatic headaches in a general population. Neurology. 1992; 42: 1225–31.Google Scholar
Lance, JW. Headaches related to sexual activity. J Neurol Neurosurg Psychiatry. 1976; 39: 1226.Google Scholar
Gomez-Tortosa, E, et al. Familial primary lateral sclerosis or dementia associated with ARG573Gly TBK1 mutation. J Neurol Neurosurg Psychiatry. 2017; 88(11): 996–7. Post Script letter.Google Scholar
Wais, V, et al. The concept and diagnostic criteria of primary lateral sclerosis. Acta Neurol Scand. 2017; 136(3): 204–11.Google Scholar
Albanese, A, Bhatia, K, Bressman, S, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013; 28: 863–73.Google Scholar
Bressman, SB. Dystonia genotypes, phenotypes, and classification. Adv Neurol. 2004; 94: 101–7.Google Scholar
Fernandez, H, Machado, A, Pandya, M. Practical approach to movement disorders: diagnosis and management. 2nd ed. New York, US: Demos Medical; 2014.Google Scholar
Fuchs, T, Gavarini, S, Saunders-Pullman, R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet. 2009; 41(3): 286–8.Google Scholar
Phibbs, FT, Hedera, P. Update on the genetics of movement disorders. Continuum (Minneap Minn). 2010; 16(1, Neurology): 77–95.Google Scholar
Saunders-Pullman, R. Genetics of dystonia. Continuum (Minneap Minn). 2008; 14(2, Neurology): 65–89.Google Scholar
Aminoff, MJ, Josephson, SA, eds. Aminoff's neurology and general medicine. 5th ed. London, UK: Elsevier; 2014.Google Scholar
Bauer, J, Gold, R, Adams, O, Lassmann, H. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS). Acta Neuropathologica [Online]. 2015; 130(6): 751–64.Google Scholar
Malek, N, Stewart, W, Greene, J. The progressive myoclonic epilepsies. Pract Neurol. 2015; 15(3): 164–71.Google Scholar
McFarland, NR. Diagnostic approach to atypical parkinsonian syndromes. Continuum (Minneap Minn). 2016; 22: 1117–42.Google Scholar
Kobylecki, C, et al. Cognitive-behavioural features of progressive supranuclear palsy syndrome overlap with frontotemporal dementia. J Neurol. 2015; 262: 916–22.Google Scholar
Josephs, KA, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase. 2005; 11: 283–96.Google Scholar
Averbuch-Heller, L, Steiner, I, Abramsky, O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 1992; 49: 1292.Google Scholar
Denton, CP, Khanna, D. Systemic sclerosis. Lancet. 2017; 390(10103): 1685–99. DOI: 10.1016/S0140-6736(17)30933-9.Google Scholar
Hietaharju, A, Jääskeläinen, S, Kalimo, H, Hietarinta, M. Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve. 1993; 16: 1204.Google Scholar
Longo, DL, Kasper, DL, Fauci, A, et al., eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill; 2016. pp. 2906–106.Google Scholar
Ciccarelli, A, Daly, AF, Beckers, A. The epidemiology of prolactinomas. Pituitary. 2005; 8(1): 3–6.Google Scholar
Wong, A, Eloy, JA, Couldwell, WT, Liu, JK. Update on prolactinomas. Part 1: clinical manifestations and diagnostic challenges. J Clin Neurosci. 2015; 22: 1562–67.Google Scholar
Wong, A, Eloy, JA, Couldwell, WT, Liu, JK. Update on prolactinomas. Part 2: treatment and management strategies. J Clin Neurosci. 2015; 22: 1568–74.Google Scholar
Vincent, GM. The long QT syndrome. Indian Pacing Electrophysiol J. 2002; 2(4): 127–42.Google Scholar
Brazis, PW, et al., eds. Peripheral nerves. In Localization in clinical neurology. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2011. Chapter 2.Google Scholar
Rodner, CM, Tinsley, BA, O'Malley, MP. Pronator syndrome and anterior interosseous nerve syndrome. J Am Acad Orthop Surg. 2013; 21(5): 268–75.Google Scholar
Roze, E, Bounolleau, P, Ducreux, D, et al. Propriospinal myoclonus revisited: Clinical, neurophysiologic, and neuroradiologic findings. Neurology. 2009; 72(15): 1301–9.Google Scholar
Brown, P. Propriospinal myoclonus: where do we go from here? Mov Disord. 2014; 29(9): 1092–3.Google Scholar
Brown, P, Rothwell, JC, Thompson, PD, Marsden, CD. Propriospinal myoclonus: evidence for spinal “pattern” generators in humans. Mov Disord. 1994; 9(5): 571–6.Google Scholar
Chokroverty, S, Walters, A, Zimmerman, T, Picone, M. Propriospinal myoclonus: a neurophysiologic analysis. Neurology. 1992; 42(8): 1591–5.Google Scholar
Antelmi, E, Provini, F. Propriospinal myoclonus: The spectrum of clinical and neurophysiological phenotypes. Sleep Med Rev. 2015; 22: 54–63.Google Scholar
Attard, G, Parker, C, Eeles, RA, et al. Prostate cancer. Lancet. 2016; 387(10013): 70–82.Google Scholar
Benjamin, R. Neurologic complications of prostate cancer. Am Fam Physician. 2002; 65(9): 1834–40. Review.Google Scholar
Cuzick, J, Thorat, MA, Andriole, G, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014; 15(11): e484–92.Google Scholar
Hong, MK, Kong, J, Namdarian, B, et al. Paraneoplastic syndromes in prostate cancer. Nat Rev Urol. 2010; 7(12): 681–92.Google Scholar
Karden, EM. Prosthetic heart valves. Feb 18, 2015. Available from http://emedicine.medscape.com/article/780702-overview#a4. Retrieved Jul 27, 2017.Google Scholar
Otto, CM, Bonow, RO. Valvular heart disease. In Mann, DL, Zipes, DP, Libby, P, Bonow, RO, Braunwald, E, eds. Braunwald's heart diseases: a textbook of cardiovascular medicine. 10th ed. Philadelphia: Elsevier/Saunders; 2015; p. 1505.Google Scholar
Papadakis, MA, McPhee, SJ. Current medical diagnosis and treatment. 58th ed. New York: McGraw-Hill Education; in press.Google Scholar
Ropper, AH, Samuels, MA, Klein, JP. Adams & Victor's principles of neurology. 10th ed. New York, NY: McGraw-Hill; 2014.Google Scholar
Goldenberg, NA, Manco-Johnson, MJ. Protein C deficiency. Haemoph Off J World Fed Hemoph. 2008; 14: 1214–21.Google Scholar
D'Angelo, A, Viganò D'Angelo, S. Protein S deficiency. Haematologica. 2008; 93: 498–501.Google Scholar
Kershaw, P, Freeman, R, Templeton, D, et al. Pseudallescheria boydii infection of the central nervous system. Arch Neurol. 1990; 47(4): 468–72.Google Scholar
Long, S, Pickering, LK, Prober, CG, eds. Principles and practice of pediatric infectious disease. 4th ed. Edinburgh: Elsevier/Saunders; 2012.Google Scholar
Aminoff, MJ, Josephson, SA, eds. Aminoff's neurology and general medicine. 5th ed. London, UK: Elsevier; 2014.Google Scholar
Roberts, J, Larson-Williams, L, Ibrahim, F, Hassoun, A. Malignant otitis externa (MOE) causing cerebral abscess and facial nerve palsy. J Hosp Med. 2010; 5(7): E6–8.Google Scholar
Longo, LP, Johnson, B. Addiction: Part I. Benzodiazepines – side effects, abuse risk and alternatives. Am Fam Physician. 2000; 61(7): 2121–8.Google Scholar
Wiegand, TJ, Burns, MM, Wiley, JF. Clinical manifestations and evaluation of mushroom poisoning. Updated Dec 9, 2016. UpToDate. Waltham, MA. https://www.uptodate.com/contents/clinical-manifestations-and-evaluation-of-mushroom-poisoning?source=search_result&search=psilocybin&selectedTitle=2∼8. Accessed Aug 8, 2018.Google Scholar
Mallick, IH, Thoufeeq, MH, Rajendran, TP. Iliopsoas abscesses. Postgrad Med J. 2004; 80(946): 459.Google Scholar
Mückley, T, Schütz, T, Kirschner, M, et al. Psoas abscess: the spine as a primary source of infection. Spine (Phila Pa 1976). 2003; 28(6): E106.Google Scholar
Lefevre, N, Bohu, Y, Klouche, S, Chewla, N, Herman, S. Complete paralysis of the quadriceps secondary to post-traumatic iliopsoas hematoma: A systematic review. Eur J Orthopaed Surg Traumatol. 2015; 25(1): 39–43.Google Scholar
Parner, SS, Carpenter, JP, Fairman, RM, Velazquez, OC, Mitchell, ME. Femoral neuropathy following retroperitoneal hemorrhage: case series and review of the literature. Ann Vasc Surg. 2006; 20(4): 536–40.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Barofsky, I, Buchholz, D, Edwin, D, Jones, B, Ravich, W. Characteristics of patients who have difficulties initiating swallowing. Annual Meeting of the Dysphagia Research Society, Lake Geneva, WI, September, 1993.Google Scholar
Leopold, NA. Dysphagia in drug-induced parkinsonism: a case report. Dysphagia. 1996; 11(2): 151–3.Google Scholar
Ravich, WJ, Wilson, RS, Jones, B, Donner, MW. Psychogenic dysphagia and globus: reevaluation of 23 patients. Dysphagia. 1989; 4(1): 35–8.Google Scholar
Tanidir, C, Hergüner, S. Mirtazapine for choking phobia: report of a pediatric case. J Child Adolesc Psychopharmacol. 2015; 25(8): 659–60.Google Scholar
Benbadis, SR, Agrawal, V, Tatum, WO. How many patients with psychogenic nonepileptic seizures also have epilepsy? Neurology. 2001; 57(5): 915–17.Google Scholar
Benbadis, SR, Hauser, WA. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure. 2000; 9(4): 280–1.Google Scholar
Diprose, W, Sundram, F, Menkes, DB. Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy. Epilepsy Behav. 2016; 56: 123–30.Google Scholar
Ettinger, AB, Devinsky, O, Weisbrot, DM, et al. Headaches and other pain symptoms among patients with psychogenic non-epileptic seizures. Seizure. 1999; 8: 424.Google Scholar
Ettinger, AB, Devinsky, O, Weisbrot, DM, Ramakrishna, RK, Goyal, A. A comprehensive profile of clinical, psychiatric, and psychosocial characteristics of patients with psychogenic nonepileptic seizures. Epilepsia. 1999; 40(9): 1292–8.Google Scholar
Ettinger, AB, Dhoon, A, Weisbrot, DM, Devinsky, O. Predictive factors for outcome of nonepileptic seizures after diagnosis. J Neuropsychiatry Clin Neurosci. 1999; 11: 458.Google Scholar
Meierkord, H, Shorvon, S. The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology. 1991; 41(10): 1643–3.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th ed. American Psychiatric Pub; 2013.Google Scholar
Engel, GL. “Psychogenic” pain and the pain-prone patient. Am J Med. 1959; 26(6): 899–918.Google Scholar
Ilgen, MA, Kleinberg, F, Ignacio, RV, et al. Noncancer pain conditions and risk of suicide. JAMA Psychiatry. 2013; 70(7): 692–7.Google Scholar
Merskey, HE. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Pain. 1986; Suppl 3: 226.Google Scholar
Sriram, T.G, Chaturvedi, SK, Gopinath, PS, Shanmugam, V. Controlled study of alexithymic characteristics in patients with psychogenic pain disorder. Psychother Psychosomat. 1987; 47(1): 11–17.Google Scholar
Siegel, AJ. Hyponatremia in psychiatric patients: update on evaluation and management. Harv Rev Psychiatry. 2008; 16(1): 13–24. DOI: 10.1080/10673220801924308.Google Scholar
Bremner, AJ, Regan, A. Intoxicated by water. Polydipsia and water intoxication in a mental handicap hospital. Br J Psychiatry. 1991; 158: 244–50.Google Scholar
Whitchurch, FT, Alexander, J. Psychogenic polydipsia: Hidden or underdiagnosed? Aust N Z J Psychiatry. 2011; 45(9): 789–90. DOI: 10.3109/00048674.2011.585457.Google Scholar
Dundas, B, Harris, M, Narasimhan, M. Psychogenic polydipsia review: Etiology, differential, and treatment. Curr Psychiatry Rep. 2007; 9(3): 236–41. DOI: 10.1007/s11920-007-0025-7.Google Scholar
Hawken, ER, Crookall, JM, Reddick, D, et al. Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: A retrospective study. Schizophr Res. 2009; 107(2–3): 128–33. DOI: 10.1016/j.schres.2008.09.029.Google Scholar
Stuart, CA, Neelon, FA, Lebovitz, HE. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med. 1980; 303(19): 1078.Google Scholar
Ödman, M, Maire, R. Chronic subjective dizziness. Acta Oto-laryngologica. 2008; 128(10): 1085–8.Google Scholar
Staab, JP. Chronic dizziness: the interface between psychiatry and neuro-otology. Curr Opin Neurol. 2006; 19(1): 41–8.Google Scholar
Strupp, M, Brandt, T. Diagnosis and treatment of vertigo and dizziness. Dtsch Arztebl Int. 2008; 105(10): 173–80. http://doi.org/10.3238/arztebl.2008.0173.Google Scholar
Fernandez, HH, Friedman, JH, Jacques, C, Rosenfeld, M. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord. 1999; 14: 484.Google Scholar
Popeo, D, Kellner, CH. ECT for Parkinson's disease. Med Hypotheses. 2009; 73(4): 468–9. DOI: 10.1016/j.mehy.2009.06.053. PubMed PMID: 19660875.Google Scholar
Rabey, JM, Treves, TA, Neufeld, MY, et al. Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson's disease. Neurology. 1995; 45: 432.Google Scholar
Ravina, B, Marder, K, Fernandez, HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007; 22(8): 1061–8.Google Scholar
Williams-Gray, CH, Foltynie, T, Lewis, SJG, Barker, RA. Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options. CNS Drugs. 2006; 20(6): 477–505. DOI: 10.2165/00023210-200620060-00004.Google Scholar
Wolters, E. Intrinsic and extrinsic psychosis in Parkinson's disease. J Neurol. 2001; 248(Suppl 3): 22–8.Google Scholar
Zahodne, LB, Fernandez, HH. Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs Aging. 2008; 25(8): 665–82. DOI: 10.2165/00002512-200825080-00004.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Greene, KA, Dickman, CA, Smith, KA, Kinder, EJ, Zabramski, JM. Self-inflicted orbital and intracranial injury with a retained foreign body, associated with psychotic depression: case report and review. Surg Neurol. 1993; 40(6): 499–503.Google Scholar
Johnson, J, Horwath, E, Weissman, MM. The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry. 1991; 48: 1075.Google Scholar
Ohayon, MM, Schatzberg, AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry. 2002; 159: 1855.Google Scholar
Shagass, C, Naiman, J, Mihalik, J. An objective test which differentiates between neurotic and psychotic depression. AMA Archiv Neurol Psychiatry. 1993; 75(5): 461–71.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Cummings, J. Organic psychoses. Delusion disorders and secondary mania. Psychiatr Clin North Am. 1996; 9(2): 293–311.Google Scholar
Keshavan, MS, Kaneko, Y. Secondary psychoses: An update. World Psychiatry. 2013; 12(1): 4–15. DOI: 10.1002/wps.20001.Google Scholar
Stern, TA, Fricchione, GL, Cassem, NH, Jellinek, M, Rosenbaum, JF. Massachusetts General Hospital handbook of general hospital psychiatry. Philadephia, PA: Saunders; 2010.Google Scholar
Weisholtz, DS, Dworetzky, BA. Epilepsy and psychosis. J Neurol Disord Stroke. 2014; 2(3): 1069.Google Scholar
Bever, C, Aquino, AV, Penn, AS, et al. Prognosis of ocular myasthenia gravis. Ann Neurol. 1998; 14: 516–9.Google Scholar
Defazio, G, Livrea, P, Lamberi, P, et al. Isolated so-called paraxis of eyelid opening: Report of 10 cases and a review of the literature. Eur Neurol. 1998; 39(4): 204–10.Google Scholar
Ferguson-Myrthil, N. Droxidopa for symptomatic neurogenic hypotension. Cardiol Rev. 2017; 25(5): 241–6. DOI: 10.1097/CRD.0000000000000151.Google Scholar
Idiaquez, J. Pure autonomic failure. Bradbury Eggleston syndrome: Case report. Rev Med Chil. 2005; 133(2): 215–8. Epub Apr 7, 2005.Google Scholar
Kuritzky, L, Espay, AJ, Gelblum, J, Payne, R, Dietrich, E. Diagnosing and treating neurogenic orthostatic hypotension in primary care. Postgrad Med. 2015; 127(7): 702–15, DOI: 10.1080/00325481.2015.1050340.Google Scholar
Feve, AP, Fenelon, G, Wallays, C, Remy, P, Guillard, A. Axial motor disturbances after hypoxic lesions of the globus pallidus. Mov Disord. 1993; 8(3): 321–6.Google Scholar
Galati, S, Stadler, C. Schizophrenia symptoms relieved by CO-induced pallidal lesion: a case report. J Neuropsychiatry Clin Neurosci. 2013; 25(2): E52–3.Google Scholar
Alquist, CR, McGoey, R, Bastian, F, Newman, W, 3rd. Bilateral globus pallidus lesions. J La State Med Soc. 2012; 164(3): 145–6.Google Scholar
Bucher, SF, Seelos, KC, Dodel, RC, et al. Pallidal lesions: structural and functional magnetic resonance imaging. Arch Neurol. 1996; 53: 682–6.Google Scholar
Aizawa, H, Kwak, S, Shimizu, T, et al. A case of adult onset pure pallidal degeneration. I. Clinical manifestations and neuropathological observations. J Neurol Sci. 1991; 102(1): 76–82.Google Scholar
Aizawa, H, Kwak, S, Shimizu, T, Mannen, T, Shibasaki, H. A case of adult onset pure pallidal degeneration. II. Analysis of neurotransmitter markers, with special reference to the termination of pallidothalamic tract in human brain. J Neurol Sci. 1991; 102(1): 83–91.Google Scholar
Bickels, J, Ben-Sira, L, Kessler, A, Wientroub, S. Primary pyomyositis. J Bone Joint Surg Am. 2002; 84–A: 2277.Google Scholar
Combs, GF. The vitamins: fundamental aspects in nutrition and health. San Diego: Elsevier; 2008. pp. 313–29.Google Scholar
Basura, GJ, et al. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry. Eur J Pediatr. 2009; 168(6): 697–704.Google Scholar
Bok, LA, et al. Long-term outcome in pyridoxine-dependent epilepsy. Dev Med Child Neurol. 2012; 54(9): 849–54.Google Scholar
van Karnebeek, CD, Jaggumantri, S. Current treatment and management of pyridoxine-dependent epilepsy. Curr Treat Options Neurol. 2015; 17(2): 335.Google Scholar
Combs, GF. The vitamins: fundamental aspects in nutrition and health. San Diego: Elsevier; 2008. pp. 313–29.Google Scholar
Perry, TA, Weerasuriya, A, Mouton, PR, Holloway, HW, Greig, NH. Pyridoxine-induced toxicity in rats: a stereological quantification of the sensory neuropathy. Exp Neurol. 2004; 190(1): 133–44.Google Scholar